Eric L. Dobmeier's most recent trade in Structure Therapeutics Inc - ADR was a trade of 51,804 Share Option (right to buy) done . Disclosure was reported to the exchange on June 23, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Structure Therapeutics Inc... | Eric L. Dobmeier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2025 | 51,804 | 51,804 | - | - | Share Option (right to buy) | |
| Janux Therapeutics Inc | Eric L. Dobmeier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 11,667 | 11,667 | - | - | Stock Option (right to buy) | |
| Janux Therapeutics Inc | Eric L. Dobmeier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 3,750 | 9,981 | - | 0 | Common Stock | |
| Jade Biosciences Inc | Eric L. Dobmeier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2025 | 23,017 | 23,017 | - | - | Stock Option (Right to Buy) | |
| Janux Therapeutics Inc | Eric L. Dobmeier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jul 2024 | 16,700 | 16,700 | - | - | Stock Option (Right to Buy) | |
| Janux Therapeutics Inc | Eric L. Dobmeier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jul 2024 | 8,350 | 8,350 | - | - | Stock Option (Right to Buy) | |
| Janux Therapeutics Inc | Eric L. Dobmeier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jul 2024 | 5,000 | 5,000 | - | 0 | Common Stock | |
| Janux Therapeutics Inc | Eric L. Dobmeier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jul 2024 | 4,111 | 4,111 | - | - | Stock Option (Right to Buy) | |
| Janux Therapeutics Inc | Eric L. Dobmeier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jul 2024 | 2,500 | 7,500 | - | 0 | Common Stock | |
| Janux Therapeutics Inc | Eric L. Dobmeier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jul 2024 | 1,231 | 6,231 | - | 0 | Common Stock | |
| Structure Therapeutics Inc... | Eric L. Dobmeier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2024 | 37,500 | 37,500 | - | - | Share Option (right to buy) | |
| Atara Biotherapeutics Inc | Eric L. Dobmeier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 79,500 | 79,500 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Atara Biotherapeutics Inc | Eric L. Dobmeier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 57,000 | 116,500 (0%) | 0% | 0 | Common Stock | |
| Atara Biotherapeutics Inc | Eric L. Dobmeier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 31,500 | 31,500 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Atara Biotherapeutics Inc | Eric L. Dobmeier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 20,500 | 59,500 (0%) | 0% | 0 | Common Stock | |
| Atara Biotherapeutics Inc | Eric L. Dobmeier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 17,500 | 17,500 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Atara Biotherapeutics Inc | Eric L. Dobmeier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 11,000 | 39,000 (0%) | 0% | 0 | Common Stock | |
| Adaptive Biotechnologies Corp | Eric L. Dobmeier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2021 | 3,759 | 3,759 | - | - | Stock Option (Right to Buy) | |
| Adaptive Biotechnologies Corp | Eric L. Dobmeier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2021 | 1,504 | 1,504 (0%) | 0% | 0 | Common Stock | |
| Adaptive Biotechnologies Corp | Eric L. Dobmeier | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2021 | 10,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Adaptive Biotechnologies Corp | Eric L. Dobmeier | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.32 per share. | 04 Jan 2021 | 10,000 | 10,000 (0%) | 0% | 6.3 | 63,200 | Common Stock |
| Adaptive Biotechnologies Corp | Eric L. Dobmeier | Director | Sale of securities on an exchange or to another person at price $ 57.76 per share. | 04 Jan 2021 | 5,725 | 992 (0%) | 0% | 57.8 | 330,676 | Common Stock |
| Adaptive Biotechnologies Corp | Eric L. Dobmeier | Director | Sale of securities on an exchange or to another person at price $ 56.10 per share. | 04 Jan 2021 | 3,283 | 6,717 (0%) | 0% | 56.1 | 184,176 | Common Stock |
| Adaptive Biotechnologies Corp | Eric L. Dobmeier | Director | Sale of securities on an exchange or to another person at price $ 58.67 per share. | 04 Jan 2021 | 592 | 400 (0%) | 0% | 58.7 | 34,733 | Common Stock |
| Adaptive Biotechnologies Corp | Eric L. Dobmeier | Director | Sale of securities on an exchange or to another person at price $ 59.46 per share. | 04 Jan 2021 | 400 | 0 (0%) | 0% | 59.5 | 23,784 | Common Stock |
| Adaptive Biotechnologies Corp | Eric L. Dobmeier | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.32 per share. | 01 Oct 2020 | 10,000 | 10,000 (0%) | 0% | 6.3 | 63,200 | Common Stock |
| Adaptive Biotechnologies Corp | Eric L. Dobmeier | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2020 | 10,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| Adaptive Biotechnologies Corp | Eric L. Dobmeier | Director | Sale of securities on an exchange or to another person at price $ 48.47 per share. | 01 Oct 2020 | 9,224 | 776 (0%) | 0% | 48.5 | 447,087 | Common Stock |
| Adaptive Biotechnologies Corp | Eric L. Dobmeier | Director | Sale of securities on an exchange or to another person at price $ 49.21 per share. | 01 Oct 2020 | 776 | 0 (0%) | 0% | 49.2 | 38,187 | Common Stock |
| Adaptive Biotechnologies Corp | Eric L. Dobmeier | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jul 2020 | 10,000 | 55,000 | - | - | Stock Option (Right to Buy) | |
| Adaptive Biotechnologies Corp | Eric L. Dobmeier | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.32 per share. | 06 Jul 2020 | 10,000 | 10,000 (0%) | 0% | 6.3 | 63,200 | Common Stock |
| Adaptive Biotechnologies Corp | Eric L. Dobmeier | Director | Sale of securities on an exchange or to another person at price $ 47.34 per share. | 06 Jul 2020 | 9,600 | 400 (0%) | 0% | 47.3 | 454,464 | Common Stock |
| Adaptive Biotechnologies Corp | Eric L. Dobmeier | Director | Sale of securities on an exchange or to another person at price $ 47.98 per share. | 06 Jul 2020 | 400 | 0 (0%) | 0% | 48.0 | 19,192 | Common Stock |